CORCEPT THERAPEUTICS INC Quarterly Marketable Securities, Current in USD from Q4 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Corcept Therapeutics Inc quarterly Marketable Securities, Current history and growth rate from Q4 2016 to Q2 2024.
  • Corcept Therapeutics Inc Marketable Securities, Current for the quarter ending June 30, 2024 was $345M, a 80.5% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $345M +$154M +80.5% Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $261M +$95.9M +58.1% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $233M -$133M -36.3% Dec 31, 2023 10-Q 2024-07-29
Q3 2023 $243M -$103M -29.7% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $191M -$144M -43% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $165M -$119M -41.8% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $365M +$219M +150% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $346M +$79.4M +29.8% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $335M +$60.2M +21.9% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $284M -$36.9M -11.5% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $146M -$219M -60% Dec 31, 2021 10-Q 2022-11-03
Q3 2021 $267M -$132M -33% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $275M -$72.3M -20.8% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $321M +$97.7M +43.9% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $365M +$120M +49% Dec 31, 2020 10-Q 2021-11-03
Q3 2020 $398M +$212M +113% Sep 30, 2020 10-Q 2020-11-03
Q2 2020 $347M +$203M +142% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $223M +$85.6M +62.4% Mar 31, 2020 10-Q 2020-05-04
Q4 2019 $245M +$79.6M +48.2% Dec 31, 2019 10-Q 2020-11-03
Q3 2019 $187M +$25.4M +15.7% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $143M +$14.6M +11.4% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $137M +$45M +48.8% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $165M +$107M +186% Dec 31, 2018 10-Q 2019-11-07
Q3 2018 $161M +$117M +266% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 $129M +$96.2M +296% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $92.2M +$77.4M +523% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $57.7M +$57.7M Dec 31, 2017 10-Q 2018-11-02
Q3 2017 $44.1M Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $32.5M Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $14.8M Mar 31, 2017 10-Q 2017-05-02
Q4 2016 $0 Dec 31, 2016 10-K 2018-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.